Implementation gaps for asthma prevention and control

Show simple item record

dc.contributor.author Tanno, Luciana K.
dc.contributor.author Haahtela, Tari
dc.contributor.author Calderon, Moises A.
dc.contributor.author Cruz, Alvaro
dc.contributor.author Demoly, Pascal
dc.contributor.author Joint Allergy Academies
dc.date.accessioned 2019-01-23T22:36:47Z
dc.date.available 2021-12-17T22:02:45Z
dc.date.issued 2017-09
dc.identifier.citation Tanno , L K , Haahtela , T , Calderon , M A , Cruz , A , Demoly , P & Joint Allergy Academies 2017 , ' Implementation gaps for asthma prevention and control ' , Respiratory Medicine , vol. 130 , pp. 13-19 . https://doi.org/10.1016/j.rmed.2017.07.006
dc.identifier.other PURE: 90296075
dc.identifier.other PURE UUID: 13500bc6-f8c2-48b4-b6d7-f076f4df8e93
dc.identifier.other WOS: 000410774800003
dc.identifier.other Scopus: 85024105583
dc.identifier.uri http://hdl.handle.net/10138/297984
dc.description.abstract Asthma and allergic diseases can start in childhood and persist throughout life, but could also be manifested later, at any time for still misunderstood reasons. They are major chronic multifactorial respiratory diseases, for which prevention, early diagnosis and treatment is recognized as a priority for the Europe's public health policy and the United Nations. Given that allergy triggers (including infections, rapid urbanization leading to loss in biodiversity, pollution and climate changes) are not expected to change in a foreseeable future, it is imperative that steps are taken to develop, strengthen and optimize preventive and treatment strategies. Currently there are good treatments for asthma, several risk factors are known (e.g., allergies, rhinitis, tobacco smoke) and tools to control the disease have been developed. However, we are still uncertain how to prevent patients from developing asthma and allergic diseases. In this paper, we list the positive and negative experiences in this field as well as analyze the missing links in the process. This critical analysis will be the basis of setting-up an effective program for prevention and making, a process labeled as "implementation gaps". (C) 2017 Elsevier Ltd. All rights reserved. en
dc.format.extent 7
dc.language.iso eng
dc.relation.ispartof Respiratory Medicine
dc.rights.uri info:eu-repo/semantics/openAccess
dc.subject Allergy
dc.subject Asthma
dc.subject Prevention
dc.subject Treatment
dc.subject World health organization (WHO)
dc.subject HYPERSENSITIVITY CONDITIONS SECTION
dc.subject PRESCHOOL-CHILDREN
dc.subject INTERNATIONAL CLASSIFICATION
dc.subject INHALED CORTICOSTEROIDS
dc.subject CHILDHOOD ASTHMA
dc.subject CONTROLLED-TRIAL
dc.subject YOUNG-CHILDREN
dc.subject DISEASES
dc.subject INTERMITTENT
dc.subject ALLERGY
dc.subject 3121 General medicine, internal medicine and other clinical medicine
dc.title Implementation gaps for asthma prevention and control en
dc.type Review Article
dc.contributor.organization Clinicum
dc.contributor.organization Department of Dermatology, Allergology and Venereology
dc.contributor.organization University of Helsinki
dc.contributor.organization HUS Inflammation Center
dc.description.reviewstatus Peer reviewed
dc.relation.doi https://doi.org/10.1016/j.rmed.2017.07.006
dc.relation.issn 0954-6111
dc.rights.accesslevel openAccess
dc.type.version publishedVersion

Files in this item

Total number of downloads: Loading...

Files Size Format View
1_s2.0_S0954611117301932_main.pdf 991.2Kb PDF View/Open

This item appears in the following Collection(s)

Show simple item record